{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:00:53Z","timestamp":1787014853920,"version":"build-2736575974"},"reference-count":134,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1111\/j.1532-5415.2007.01335.x","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T03:35:03Z","timestamp":1191382503000},"source":"Crossref","is-referenced-by-count":26,"title":["Quality Indicators for the Care of Dementia in Vulnerable Elders"],"prefix":"10.1111","volume":"55","author":[{"given":"Denise G.","family":"Feil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sultzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.18.2335"},{"key":"e_1_2_5_3_2","first-page":"2219","article-title":"The decreasing prevalence of reversible dementias","volume":"163","author":"Clarfield AM.","year":"2003","journal-title":"An updated meta-analysis"},{"key":"e_1_2_5_4_2","first-page":"2562","volume-title":"Comprehensive Textbook of Psychiatry","author":"Small GW.","year":"1995"},{"key":"e_1_2_5_5_2","first-page":"1226","article-title":"Seven\u2010year survival rate after age 85 years","volume":"55","author":"Aevarsson O","year":"1998","journal-title":"Relation to Alzheimer disease and vascular dementia"},{"key":"e_1_2_5_6_2","first-page":"1119","article-title":"Alzheimer disease in the US population","volume":"60","author":"Hebert LE","year":"2003","journal-title":"Prevalence estimates using the 2000 census"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199821001-00002"},{"key":"e_1_2_5_8_2","first-page":"88","article-title":"Estimating the costs of caring for people with Alzheimer disease in California","volume":"22","author":"Fox PJ","year":"2001","journal-title":"2000\u20132040"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200407000-00003"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.489"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.136"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.3.427"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.20.2182"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540210033030"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2389.2003.51272.x"},{"key":"e_1_2_5_16_2","first-page":"1133","article-title":"Practice parameter","volume":"56","author":"Petersen RC","year":"2001","journal-title":"Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1470"},{"key":"e_1_2_5_18_2","first-page":"M534","article-title":"The clock drawing test","volume":"54","author":"Borson S","year":"1999","journal-title":"Utility for dementia detection in multiethnic elders"},{"key":"e_1_2_5_19_2","volume-title":"Screening for Dementia: Recommendations and Rationale (AHRQ Publication no. 03\u2010520A)","author":"U.S. Preventive Services Task Force.","year":"2003"},{"key":"e_1_2_5_20_2","first-page":"274","article-title":"The informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)","volume":"16","author":"Jorm AF.","year":"2004","journal-title":"A review"},{"key":"e_1_2_5_21_2","volume-title":"Guidelines for the Diagnosis and Management of Dementia in Primary Care","author":"Kaiser Permanente Care Management Institute's Dementia Guidelines Workgroup.","year":"2004"},{"key":"e_1_2_5_22_2","first-page":"1195","article-title":"Dementia diagnostic guidelines","volume":"48","author":"Beck C","year":"2000","journal-title":"Methodologies, results, and implementation costs"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540330081018"},{"key":"e_1_2_5_24_2","first-page":"705","article-title":"Blessed\u2010Roth Dementia Scale (DS)","volume":"24","author":"Blessed G","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610295001815"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.92"},{"key":"e_1_2_5_27_2","first-page":"847","article-title":"The continuing challenge of inappropriate prescribing in the elderly","volume":"42","author":"Liu GG","year":"2002","journal-title":"An update of the evidence"},{"key":"e_1_2_5_28_2","first-page":"4","article-title":"Health outcomes and polypharmacy in elderly individuals","volume":"31","author":"Frazier SC.","year":"2005","journal-title":"An integrated literature review"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E230"},{"key":"e_1_2_5_30_2","first-page":"69","article-title":"The association of inappropriate drug use with hospitalisation and mortality","volume":"22","author":"Klarin I","year":"2005","journal-title":"A population-based study of the very old"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915010-00002"},{"key":"e_1_2_5_32_2","first-page":"5","article-title":"Complexity of medication use in the Veterans Affairs healthcare system","volume":"11","author":"Preskorn SH","year":"2005","journal-title":"Part I: Outpatient use in relation to age and number of prescribers"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100001190"},{"key":"e_1_2_5_34_2","volume-title":"Practice Guideline for the Treatment of Patients with Alzheimer's Disease and Other Dementias of Late Life. American Psychiatric Association Guideline","year":"1997"},{"key":"e_1_2_5_35_2","first-page":"101","article-title":"Drug\u2010induced cognition disorders in the elderly","volume":"21","author":"Gray SL","year":"1999","journal-title":"Incidence, prevention and management"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610297004729"},{"key":"e_1_2_5_37_2","first-page":"789","article-title":"Diagnosis, management, and treatment of Alzheimer disease","volume":"159","author":"Richards SS","year":"1999","journal-title":"A guide for the internist"},{"key":"e_1_2_5_38_2","first-page":"466","article-title":"Reversible dementia","volume":"242","author":"Weytingh MD","year":"1995","journal-title":"More than 10% or less than 1%? A quantitative review"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb03641.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50020.x"},{"key":"e_1_2_5_41_2","unstructured":"American Academy of Neurology.American Academy of Neurology guideline summary for clinicians: Detection diagnosis and management of dementia [on\u2010line]. Available athttp:\/\/www.aan.com\/professionals\/practice\/index.cfmAccessed February 13 2004."},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.031922"},{"key":"e_1_2_5_43_2","first-page":"269","article-title":"Primary and secondary syphilis\u2014United States, 2003\u20132004","volume":"55","author":"Centers for Disease Control and Prevention.","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200103000-00002"},{"key":"e_1_2_5_45_2","first-page":"315","article-title":"Neuroimaging and early diagnosis of Alzheimer disease","volume":"226","author":"Petrella JR","year":"2003","journal-title":"A look to the future"},{"key":"e_1_2_5_46_2","first-page":"1","article-title":"A meta\u2010analysis of structural and functional brain imaging in dementia of the Alzheimer's type","volume":"13","author":"Zakzanis KK","year":"2003","journal-title":"A neuroimaging profile"},{"key":"e_1_2_5_47_2","first-page":"1143","article-title":"Practice parameter","volume":"56","author":"Knopman DS","year":"2001","journal-title":"Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040223"},{"key":"e_1_2_5_49_2","volume-title":"Dementia Identification and Assessment: Guidelines for Primary Care Practitioners","year":"1997"},{"key":"e_1_2_5_50_2","first-page":"822","article-title":"Higher frequency of dementia in older HIV\u20101 individuals","volume":"63","author":"Valcour V","year":"2004","journal-title":"The Hawaii Aging with HIV-1 Cohort"},{"issue":"1","key":"e_1_2_5_51_2","first-page":"S79","article-title":"Cognitive impairment in older HIV\u20101\u2010seropositive individuals","volume":"18","author":"Valcour VG","year":"2004","journal-title":"Prevalence and potential mechanisms"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200109010-00004"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1238"},{"key":"e_1_2_5_54_2","first-page":"737","article-title":"Treating depression in Alzheimer disease","volume":"60","author":"Lyketsos CG","year":"2003","journal-title":"Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS"},{"key":"e_1_2_5_55_2","first-page":"1154","article-title":"Practice parameter","volume":"56","author":"Doody RS","year":"2001","journal-title":"Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology"},{"key":"e_1_2_5_56_2","volume-title":"Pharmacological Treatment of Dementia. Summary, Evidence Report\/Technology Assessment No. 97","author":"Santaguida PS","year":"2004"},{"key":"e_1_2_5_57_2","doi-asserted-by":"crossref","unstructured":"BirksJS HarveyR.Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev2006;(1):CD00119.","DOI":"10.1002\/14651858.CD001190.pub2"},{"key":"e_1_2_5_58_2","doi-asserted-by":"crossref","unstructured":"LoyC SchneiderL.Galantamine for Alzheimer's disease. Cochrane Database Syst Rev2004;(4):CD001747.","DOI":"10.1002\/14651858.CD001747.pub2"},{"key":"e_1_2_5_59_2","unstructured":"BirksJ EvansG IakovidouVet al.Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev2000;(4):CD001191."},{"key":"e_1_2_5_60_2","first-page":"559","article-title":"Efficacy and safety of donepezil in patients with more severe Alzheimer's disease","volume":"20","author":"Feldman H","year":"2005","journal-title":"A subgroup analysis from a randomized, placebo-controlled trial"},{"key":"e_1_2_5_61_2","first-page":"1057","article-title":"Donepezil in patients with severe Alzheimer's disease","volume":"367","author":"Winblad B","year":"2006","journal-title":"Double-blind, parallel-group, placebo-controlled study"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2001.49266.x"},{"key":"e_1_2_5_63_2","unstructured":"FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease [on\u2010line] October 13 2006. Available athttp:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2006\/NEW01491.htmlAccessed December 1 2006."},{"key":"e_1_2_5_64_2","first-page":"141","article-title":"Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia","volume":"229","author":"Passmore AP","year":"2005","journal-title":"Results from large-scale clinical trials"},{"issue":"1","key":"e_1_2_5_65_2","first-page":"CD004395","article-title":"Donepezil for vascular cognitive impairment","author":"Malouf R","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"e_1_2_5_66_2","first-page":"40","article-title":"Efficacy and safety of galantamine in patients with dementia with Lewy bodies","volume":"17","author":"Edwards KR","year":"2004","journal-title":"A 12-week interim analysis"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.11.2027"},{"key":"e_1_2_5_68_2","doi-asserted-by":"crossref","unstructured":"WildR PettitT BurnsA.Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev2003;(3):CD003672","DOI":"10.1002\/14651858.CD003672"},{"key":"e_1_2_5_69_2","unstructured":"FDA Approves the First Treatment for Dementia of Parkinson's Disease [on\u2010line]. June 27 2006. Available athttp:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2006\/NEW01399.htmlAccessed December 1 2006."},{"key":"e_1_2_5_70_2","first-page":"1","article-title":"The Expert Consensus Guideline Series","author":"Alexopoulos GS","year":"2005","journal-title":"Treatment of dementia and its behavioral disturbances"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000221334.65330.55"},{"issue":"2","key":"e_1_2_5_72_2","article-title":"Memantine for dementia","author":"Aereosa SA","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.5.1317"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70221-0"},{"key":"e_1_2_5_75_2","first-page":"2046","article-title":"The prevention of dementia with antihypertensive treatment","volume":"162","author":"Forette F","year":"2002","journal-title":"New evidence from the Systolic Hypertension in Europe (Syst-Eur) study"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00188-4"},{"key":"e_1_2_5_77_2","first-page":"867","article-title":"Statins and cognition","volume":"10","author":"Xiong GL","year":"2005","journal-title":"What can we learn from existing randomized trials?"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70248-9"},{"key":"e_1_2_5_79_2","first-page":"753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease","volume":"62","author":"Sparks DL","year":"2005","journal-title":"Preliminary results"},{"key":"e_1_2_5_80_2","article-title":"Use of calcium antagonists and cognitive decline in old age. The Leiden 85\u2010plus study","author":"Trompet S","journal-title":"Neurobiol Aging"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.176.6.557"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6712.1375"},{"key":"e_1_2_5_83_2","first-page":"730","article-title":"An intervention that delays institutionalization of Alzheimer's disease patients","volume":"33","author":"Mittelman MS","year":"1993","journal-title":"Treatment of spouse-caregivers"},{"key":"e_1_2_5_84_2","first-page":"547","article-title":"Primary care interventions for dementia caregivers","volume":"43","author":"Burns R","year":"2003","journal-title":"2-year outcomes from the REACH study"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1990.tb03544.x"},{"key":"e_1_2_5_86_2","first-page":"325","article-title":"Depressive disorders in caregivers of dementia patients","volume":"9","author":"Cuijpers P.","year":"2005","journal-title":"A systematic review"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550160083043"},{"key":"e_1_2_5_88_2","volume-title":"The BPSD Educational Pack","author":"International Psychogeriatric Association.","year":"2003"},{"key":"e_1_2_5_89_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610204000468"},{"issue":"3","key":"e_1_2_5_90_2","first-page":"497","article-title":"Behavioral and psychological signs and symptoms of dementia","volume":"8","author":"Finkel SI","year":"1996","journal-title":"A consensus statement on current knowledge and implications for research and treatment"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.4.643"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1987.tb01398.x"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.1037\/0882-7974.20.1.100"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2090"},{"key":"e_1_2_5_95_2","first-page":"2308","article-title":"The Neuropsychiatric Inventory","volume":"44","author":"Cummings JL","year":"1994","journal-title":"Comprehensive assessment of psychopathology in dementia"},{"key":"e_1_2_5_96_2","first-page":"549","article-title":"Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia","volume":"40","author":"Sultzer DL","year":"1992","journal-title":"The Neurobehavioral Rating Scale"},{"issue":"3","key":"e_1_2_5_97_2","first-page":"309","article-title":"Conceptualization of agitation","volume":"8","author":"Cohen\u2010Mansfield J.","year":"1996","journal-title":"Results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument"},{"issue":"3","key":"e_1_2_5_98_2","first-page":"301","article-title":"Behavioral pathology in Alzheimer's disease (BEHAVE\u2010AD) rating scale","volume":"8","author":"Reisberg B","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.10.1965"},{"key":"e_1_2_5_100_2","first-page":"596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia","volume":"293","author":"Sink KM","year":"2005","journal-title":"A review of the evidence"},{"key":"e_1_2_5_101_2","first-page":"789","article-title":"The efficacy of psychosocial approaches to behaviour disorders in dementia","volume":"33","author":"Opie J","year":"1999","journal-title":"A systematic literature review"},{"key":"e_1_2_5_102_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061240"},{"key":"e_1_2_5_103_2","first-page":"596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia","volume":"293","author":"Sink KM","year":"2005","journal-title":"A review of the evidence"},{"key":"e_1_2_5_104_2","first-page":"191","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia","volume":"14","author":"Schneider LS","year":"2006","journal-title":"Meta-analysis of randomized, placebo-controlled trials"},{"key":"e_1_2_5_105_2","first-page":"1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia","volume":"294","author":"Schneider LS","year":"2005","journal-title":"Meta-analysis of randomized placebo-controlled trials"},{"key":"e_1_2_5_106_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052827"},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000129990.32253.7B"},{"key":"e_1_2_5_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90172-5"},{"key":"e_1_2_5_109_2","doi-asserted-by":"publisher","DOI":"10.1017\/S104161020200858X"},{"key":"e_1_2_5_110_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.3.460"},{"key":"e_1_2_5_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199705010-00008"},{"key":"e_1_2_5_112_2","first-page":"85","article-title":"The relationship between neuropsychological functioning and driving ability in dementia","volume":"18","author":"Reger MA","year":"2004","journal-title":"A meta-analysis"},{"key":"e_1_2_5_113_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2003.51481.x"},{"key":"e_1_2_5_114_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000139301.01177.35"},{"key":"e_1_2_5_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-200101000-00002"},{"key":"e_1_2_5_116_2","first-page":"232","article-title":"Driving and dementia","volume":"17","author":"Brown LB","year":"2004","journal-title":"A review of the literature"},{"key":"e_1_2_5_117_2","first-page":"2205","article-title":"Practice parameter","volume":"54","author":"Dubinsky RM","year":"2000","journal-title":"Risk of driving and Alzheimer's disease (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology"},{"key":"e_1_2_5_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb03023.x"},{"key":"e_1_2_5_119_2","first-page":"31","article-title":"Checklist for managing the dementia patient","volume":"46","author":"Jarvik LF","year":"1991","journal-title":"Geriatrics"},{"key":"e_1_2_5_120_2","first-page":"46","article-title":"Physical restraint use on people with dementia","volume":"22","author":"Wang WW","year":"2005","journal-title":"A review of the literature"},{"key":"e_1_2_5_121_2","first-page":"139","article-title":"Physical restraints in nursing homes","volume":"55","author":"Castle NG","year":"1998","journal-title":"A review of the literature since the Nursing Home Reform Act of 1987"},{"key":"e_1_2_5_122_2","doi-asserted-by":"publisher","DOI":"10.3928\/0098-9134-19890201-06"},{"key":"e_1_2_5_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/32.6.762"},{"key":"e_1_2_5_124_2","first-page":"30","article-title":"Evaluation of patient falls","volume":"9","author":"Innes EM","year":"1983","journal-title":"QRB Qual Rev Bull"},{"key":"e_1_2_5_125_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2001.49286.x"},{"key":"e_1_2_5_126_2","first-page":"587","article-title":"The effect of staff training on the use of restraint in dementia","volume":"20","author":"Testad I","year":"2005","journal-title":"A single-blind randomised controlled trial"},{"key":"e_1_2_5_127_2","first-page":"17","article-title":"Short\u2010term effects of an educational intervention on physical restraint use","volume":"6","author":"Huizing AR","year":"2006","journal-title":"A cluster randomized trial"},{"key":"e_1_2_5_128_2","volume-title":"Research\u2010Based Protocol: Alzheimer's Disease and Chronic Dementing Illnesses","author":"Hall GR.","year":"1996"},{"key":"e_1_2_5_129_2","volume-title":"Research\u2010Based Protocol: Restraints","author":"Ledford L","year":"1996"},{"key":"e_1_2_5_130_2","unstructured":"UCLA Medical Center Standards of Care Involuntary Physical Restraint. Policy No. 0030 Los Angeles CA: UCLA Medical Center 1998."},{"key":"e_1_2_5_131_2","volume-title":"State Operations Manual: Provider Certification","author":"Department of Health and Human Services, Health Care Financing Administration","year":"1995"},{"key":"e_1_2_5_132_2","volume-title":"Dementia. Clinical Practice Guidelines","year":"1998"},{"key":"e_1_2_5_133_2","volume-title":"American Geriatrics Society Position Statement: Guidelines for Restraint Use","year":"1991"},{"key":"e_1_2_5_134_2","volume-title":"Use of Restraints for Patients in Nursing Homes. Report 4 of the Council of Scientific Affairs (A\u201097)","year":"1997"},{"key":"e_1_2_5_135_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.1180"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01335.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01335.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:57:01Z","timestamp":1762199821000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01335.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":134,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01335.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01335.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}